Gal-3 derived from mesenchymal stem cells removed the aberrant forms of tau and reduced hyperphosphorylation of tau in vitro and in vivo and also ameliorated deficits in spatial learning and memory, confirming its potential therapeutic role in AD pathology and accompanying memory impairment (Lim et al., 2020). Here, MAPT is linked to Alzheimer disease.